These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15694020)

  • 21. [Study of DLC1 gene expression in nasopharyngeal carcinoma].
    Peng H; Zhao T; Yao K
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 37(6):454-7. PubMed ID: 12966809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differentially expressed gene in nasopharyngeal carcinoma cell lines with various metastatic potentialities].
    Zhang L; Song L; Ma Y; Huang B; Liang Q; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):430-4. PubMed ID: 12485491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
    Xie L; Xu L; He Z; Zhou W; Wang L; Zhang L; Lan K; Ren C; Liu W; Yao K
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):400-6. PubMed ID: 10929762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of a nude mouse model of nasopharyngeal carcinoma lymph node metastasis and screening of the metastasis-related signature genes].
    Leng L; Liu TF; Huang ZX; Xie WB; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1519-22. PubMed ID: 18819858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and clinical significance of cyclin E2 in nasopharyngeal carcinoma].
    Zhao GH; Xie GQ; Miao YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):291-3. PubMed ID: 22394640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profile changes and possible molecular subtypes in differentiated-type nonkeratinizing nasopharyngeal carcinoma.
    Wang S; Li X; Li ZG; Lu J; Fang WY; Ding YQ; Yao KT
    Int J Cancer; 2011 Feb; 128(4):753-62. PubMed ID: 20473882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma.
    Zhu Q; Cao SM; Lin HX; Yang Q; Liu SL; Guo L
    Tumour Biol; 2016 Mar; 37(3):3349-57. PubMed ID: 26443540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization.
    Yang XY; Ren CP; Wang L; Li H; Jiang CJ; Zhang HB; Zhao M; Yao KT
    Cell Oncol; 2005; 27(4):215-23. PubMed ID: 16308470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential gene expression profiling for identification of protective transcription factors in different subtypes of nasopharyngeal carcinoma].
    Huang C; Lin P; Wang J; Huang Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1565-70. PubMed ID: 24273254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Identification of differentially expressed genes in primary cultured nasopharyngeal carcinoma cells by cDNA microarray].
    Li RP; Shao JY; Deng L; Zeng MS; Song LB; Li MZ; Wu QL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1156-60. PubMed ID: 17715014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.
    Lo PH; Xie D; Chan KC; Xu FP; Kuzmin I; Lerman MI; Law S; Chua D; Sham J; Lung ML
    Cancer Lett; 2007 Nov; 257(2):199-205. PubMed ID: 17720308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of osteoblast-specific factor 2 and polymeric immunoglobulin receptor genes in nasopharyngeal carcinoma.
    Chang Y; Lee TC; Li JC; Lai TL; Chua HH; Chen CL; Doong SL; Chou CK; Sheen TS; Tsai CH
    Head Neck; 2005 Oct; 27(10):873-82. PubMed ID: 16136586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].
    Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J
    Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of desmoglein 3 in nasopharyngeal carcinoma: research of 22 cases].
    Liu ZQ; Tian YQ; Ma FR; Zhu L; Hu YF
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2541-3. PubMed ID: 18067828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma.
    Chang CS; Chang JH; Hsu NC; Lin HY; Chung CY
    BMC Cancer; 2007 May; 7():88. PubMed ID: 17524139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling.
    Shi W; Bastianutto C; Li A; Perez-Ordonez B; Ng R; Chow KY; Zhang W; Jurisica I; Lo KW; Bayley A; Kim J; O'Sullivan B; Siu L; Chen E; Liu FF
    Int J Cancer; 2006 Nov; 119(10):2467-75. PubMed ID: 16858677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expressions of P16 and nm23-H1 in nasopharyngeal cacinoma and their clinical significance].
    Chen SY; Wang XQ; Li XM; Chen YX; Wu CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):342-4, 348. PubMed ID: 15772009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.